INTERCEPT PHARMACEUTICALS
(45845P108)
Funds Reporting Holdings of INTERCEPT PHARMACEUTICALS according to 13F filings
| Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
|---|---|---|---|---|---|
| Senvest Management LLC | 1,026,388 | $81,670k | Jun 30, 2019 | Aug 13, 2019 | |
| Sarissa Capital Management LP | 757,000 | $60,234k | Jun 30, 2019 | Aug 14, 2019 | |
| Consonance Capital Management LP | 388,470 | $30,911k | Jun 30, 2019 | Aug 14, 2019 | |
| Altrinsic Global Advisors LLC | 159,145 | $12,663k | Jun 30, 2019 | Aug 14, 2019 | |
| Emerald Mutual Fund Advisers Trust | 137,898 | $10,973k | Jun 30, 2019 | Jul 31, 2019 | |
| Columbia Wanger Asset Management LLC | 117,425 | $6,860k | Dec 31, 2017 | Feb 13, 2018 | |
| Spark Investment Management LLC | 69,700 | $5,546k | Jun 30, 2019 | Aug 12, 2019 | |
| Scopia Capital Management LP | 56,794 | $4,519k | Jun 30, 2019 | Aug 14, 2019 | |
| Tekla Capital Management LLC | 53,857 | $4,285k | Jun 30, 2019 | Aug 14, 2019 | |
| Pacific VIEW Asset Management LLC | 51,832 | $4,124k | Jun 30, 2019 | Aug 14, 2019 | |
| Rock Springs Capital Management LP | 50,000 | $3,979k | Jun 30, 2019 | Aug 14, 2019 | |
| Granahan Investment Management Inc | 48,305 | $3,844k | Jun 30, 2019 | Aug 14, 2019 | |
| DLD Asset Management LP | 15,000 | $1,193k | Put | Jun 30, 2019 | Aug 14, 2019 |
| QS Investors LLC | 12,860 | $1,024k | Jun 30, 2019 | Aug 14, 2019 | |
| Tributary Capital Management LLC | 12,600 | $1,003k | Jun 30, 2019 | Jul 11, 2019 | |
| Campbell & Company Investment Adviser LLC | 5,174 | $412k | Jun 30, 2019 | Jul 10, 2019 | |
| QVT Financial LP | 3,763 | $299k | Jun 30, 2019 | Aug 14, 2019 | |
| Prelude Capital Management LLC | 154 | $12k | Jun 30, 2019 | Aug 14, 2019 |